New skin patch could ease nausea for stem cell transplant patients
NCT ID NCT04150614
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a granisetron skin patch works better than ondansetron pills for preventing nausea and vomiting in people getting chemotherapy before a stem cell transplant. About 90 patients will be enrolled and randomly assigned to one of the two treatments. The goal is to see which approach helps more patients avoid vomiting and the need for extra medication during the first 24 hours after chemotherapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- granisetron transdermal patch
- What this could lead to
- If the patch works better, it could offer a more convenient and effective way to control nausea and vomiting during stem cell transplant preparation.
- What could go wrong
- This is a small, early-phase study with only 90 participants, so results may not apply to everyone. The patch may not be more effective than the standard pill, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAUSEA WITH VOMITING CHEMOTHERAPY-INDUCED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Illinois Cancer Center
RECRUITINGChicago, Illinois, 60612, United States